Product image of Levobupivacaïne Molteni (Levobupivacaine) supplied by GNH India

Levobupivacaïne Molteni

Active Ingredient:
Levobupivacaine
Origin:
EU

Levobupivacaïne Molteni (Levobupivacaine)

Levobupivacaine, the active ingredient in Levobupivacaïne Molteni, is a local anesthetic presented as a sterile solution for epidural use. It provides regional loss of sensation for surgical, obstetric and other procedures requiring epidural anesthesia.\n\nGNH India supplies Levobupivacaïne Molteni as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

L. Molteni And C. Dei F.Lli Alitti Società Di Esercizio S.P.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Levobupivacaine is employed in regional anesthesia and analgesia for several clinical situations.\n\n- Epidural anesthesia: produces reliable sensory block for surgeries and procedures performed under regional technique.\n- Surgical anesthesia: offers dense anesthesia for operations where a regional block is preferred over general anesthesia.\n- Obstetric analgesia: provides effective pain relief during labor while preserving maternal consciousness and fetal safety.

How It Works

  • Levobupivacaine reversibly binds to voltage‑gated sodium channels on neuronal membranes, stabilising the inactive state of the channel. This inhibition prevents the initiation and propagation of action potentials, thereby blocking nerve impulse conduction and producing loss of sensation in the targeted area.

Side Effects

  • Levobupivacaine may cause a range of adverse reactions, from mild to severe.\n\nCommon Side Effects:\n- Hypotension: reduced blood pressure following sympathetic block.\n- Bradycardia: slower heart rate due to vagal stimulation.\n- Nausea or vomiting: gastrointestinal upset after regional block.\n- Dizziness or light‑headedness: transient feeling of unsteadiness.\n- Headache: post‑dural puncture or tension‑type headache.\n\nSerious or Rare Side Effects:\n- Cardiac arrest: severe cardiotoxicity, especially with high plasma concentrations.\n- Seizures: central nervous system toxicity from excessive drug levels.\n- Respiratory depression: inadequate ventilation due to high spinal block.\n- Allergic reaction: anaphylaxis or severe skin rash.\n- Prolonged motor block: extended loss of muscle function beyond expected duration.\n- Neurotoxicity: rare peripheral nerve injury or persistent paresthesia.

Precautions & Warnings

  • Before using Levobupivacaïne Molteni, clinicians should consider several safety measures.\n\n- Cardiovascular assessment: evaluate patient’s heart rate and blood pressure prior to administration.\n- Allergy check: avoid use in individuals with known hypersensitivity to amide‑type local anesthetics.\n- Hepatic function: use caution and consider dose adjustment in patients with liver impairment.\n- Obstetric patients: monitor fetal heart rate and maternal hemodynamics closely during labor analgesia.\n- Concomitant local anesthetics: avoid mixing with other regional anesthetics to reduce systemic toxicity risk.\n- Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Avoid Interactions

  • Levobupivacaïne Molteni can interact with other medicines, altering its safety profile.\n\nMajor Interactions (Avoid):\n- Other local anesthetics: additive systemic toxicity may occur.\n- Class I antiarrhythmic agents (e.g., quinidine): can enhance cardiotoxic effects.\n\nModerate Interactions (Monitor Closely):\n- Beta‑adrenergic blockers: may potentiate bradycardia and hypotension.\n- Calcium channel blockers: can affect cardiac conduction when combined.\n- Central nervous system depressants (e.g., benzodiazepines, opioids): may increase sedation and respiratory depression.\n- Diuretics: may exacerbate hypotensive response after epidural block.

Frequently Asked Questions

Levobupivacaïne Molteni is a sterile solution of levobupivacaine used for epidural anesthesia, surgical anesthesia, and obstetric analgesia. It provides regional loss of sensation, allowing procedures to be performed without general anesthesia and offering effective pain relief during labor.

Levobupivacaine blocks voltage‑gated sodium channels on nerve membranes, stabilising them in an inactive state. This prevents the initiation and propagation of action potentials, thereby interrupting nerve impulse transmission and producing a reversible loss of sensation in the targeted area.

The dose of Levobupivacaïne Molteni is determined by the prescribing clinician based on the specific procedure, patient characteristics, and desired level of block. Healthcare professionals calculate the appropriate volume and concentration to achieve effective anesthesia while minimizing toxicity.

Safety data for levobupivacaine in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. Use is generally reserved for obstetric analgesia when benefits outweigh potential risks, and it should be administered under close medical supervision.

To order Levobupivacaïne Molteni, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levobupivacaïne Molteni is the S‑enantiomer of bupivacaine, offering a similar duration of action with a lower risk of cardiotoxicity and central nervous system toxicity. Compared with racemic bupivacaine, it provides a more favourable safety profile while maintaining effective regional anesthesia.

Store Levobupivacaïne Molteni at 2‑8 °C in a refrigerator, protected from light and moisture. Do not freeze the solution. Keep the vial in its original packaging until use and discard any product that appears discolored or contains particles.

Levobupivacaïne Molteni is administered by a qualified healthcare professional via the epidural route. The solution is injected into the epidural space using a sterile technique, allowing the drug to diffuse to nearby nerve roots and produce a regional block.

Serious risks include cardiac arrest, severe hypotension, bradycardia, seizures, respiratory depression, and allergic reactions. Early recognition of signs such as sudden drop in blood pressure, arrhythmias, altered mental status, or difficulty breathing is essential for prompt intervention.

Levobupivacaïne Molteni should be avoided in patients with known hypersensitivity to amide‑type local anesthetics, those with severe cardiac conduction disorders, uncontrolled epilepsy, or significant hepatic impairment without dose adjustment. It is also contraindicated when used in combination with other local anesthetics without careful monitoring.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Levobupivacaine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT